Benjamin Nathaniel Kaplan Mycotopia Therapies, Inc. (TPIA) insider trading activity

TPIA Quotes by TradingView

Benjamin Nathaniel Kaplan is CEO of Mycotopia Therapies, Inc.. Currently has a direct ownership of 95.3 Million shares of TPIA, which is worth approximately $7.62 Million. The most recent transaction as insider was on Jul 25, 2025, when has been sold 75,000,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 95.3M
n/a 3M change
n/a 12M change
Total Value Held $7.62 Million

BENJAMIN NATHANIEL KAPLAN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 25 2025
BUY
Grant, award, or other acquisition
-
75,000,000 Added 44.05%
95,250,000 Common Stock

Also insider at

STEK
Stemtech Corp
Director
BNK

Benjamin Nathaniel Kaplan

CEO
North Miami, FL

Track Institutional and Insider Activities on TPIA

Follow Mycotopia Therapies, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TPIA shares.

Notify only if

Insider Trading

Get notified when an Mycotopia Therapies, Inc. insider buys or sells TPIA shares.

Notify only if

News

Receive news related to Mycotopia Therapies, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TPIA